Fluorescence Encoding-Enabled Multiplexed Droplet Digital Recombinase Polymerase Amplification-CRISPR/Cas12a Assay for Rapid Screening of Lower Respiratory Tract Infection-Associated Bacterial Pathogens
Authors:
- 15 October 2026
- journal article
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 20 (42) , 28655-28667
Abstract
Digital RPA-CRISPR/Cas12a assays enable accurate nucleic acid quantification; however, their multiplexing capacity is inherently limited by signal confounding arising from the promiscuous trans-cleavage activity of Cas12a effectors. To overcome this limitation, we developed a fluorescence encoding-enabled multiplexed droplet digital RPA-CRISPR/Cas12a (FLEMD-CRISPR) assay that integrates combinatorial fluorescence encoding, deterministic droplet pairing within a calabash-shaped microwell array, and a machine learning-assisted decoding pipeline. In FLEMD-CRISPR, small-volume fluorescence-encoded CRISPR/Cas12a droplets, each assigned a unique spectral signature corresponding to a specific crRNA, are one-to-one paired with large-volume RPA droplets. Following RPA amplification and droplet merging, Cas12a-mediated reporter cleavage occurs only in droplets containing target amplicons. The decoding pipeline then localizes droplets, classifies their colors to assign crRNA identities, and finally detects positive signals, enabling high-throughput, hands-off analysis of the entire droplet array. FLEMD-CRISPR enabled simultaneous quantification of nucleic acid targets from eight major lower respiratory tract infection-associated bacterial pathogens, showing strong linear correlation (R2 = 0.9987–0.9998) and consistent detection efficiency (slopes = 0.9849–1.0198) relative to single-plex digital PCR. The complete workflow, from sample preparation to final readout, can be completed within 2 h. Clinical validation using 30 bronchoalveolar lavage fluid samples showed that the bacterial detection outcomes of FLEMD-CRISPR were highly concordant with standard-of-care culture, achieving 100% (20/20) positive percent agreement and 99.1% (218/220) negative percent agreement. By enabling panel reconfiguration through simple modifications of the droplet encoding library, FLEMD-CRISPR provides a flexible platform for the development of highly multiplexed digital CRISPR assays.Keywords
Funding Information
- Natural Science Foundation of Guangdong Province (2024A1515011810)
- Natural Science Foundation of Guangdong Province (2024A1515220086)
- Science Foundation of Guangzhou First People?s Hospital (PT82372345)
- Science Foundation of Guangzhou First People?s Hospital (PT82472372)
- Science Foundation of Guangzhou First People?s Hospital (PT82572669)
- National Natural Science Foundation of China (NSFC) (82372345)
- National Natural Science Foundation of China (NSFC) (82472372)
- National Natural Science Foundation of China (NSFC) (82572669)
- Clinical Research Hongmian Project of Guangzhou First People?s Hospital (HM2025002)
This publication has 45 references indexed in Scilit:
- Droplet pairing-merging enabled digital RPA-CRISPR/Cas12a (DIMERIC) assay for rapid and precise quantification of Hepatitis B Virus DNABiosensors and Bioelectronics, 2025
- Multiplex bacteria detection using one-pot CRISPR/Cas13a-based droplet microfluidicsBiosensors and Bioelectronics, 2023
- Digital Recombinase Polymerase Amplification, Digital Loop‐Mediated Isothermal Amplification, and Digital CRISPR‐Cas Assisted Assay: Current Status, Challenges, and PerspectivesSmall, 2023
- CRISPR Assays for Disease Diagnosis: Progress to and Barriers Remaining for Clinical ApplicationsAdvanced Science, 2023
- Droplet Encoding‐Pairing Enabled Multiplexed Digital Loop‐Mediated Isothermal Amplification for Simultaneous Quantitative Detection of Multiple PathogensAdvanced Science, 2023
- DropCRISPR: A LAMP-Cas12a based digital method for ultrasensitive detection of nucleic acidBiosensors and Bioelectronics, 2022
- Digital CRISPR-based method for the rapid detection and absolute quantification of nucleic acidsBiomaterials, 2021
- Sensitive quantitative detection of SARS-CoV-2 in clinical samples using digital warm-start CRISPR assayBiosensors and Bioelectronics, 2021
- Digital CRISPR/Cas‐Assisted Assay for Rapid and Sensitive Detection of SARS‐CoV‐2Advanced Science, 2020
- Individual Control and Quantification of 3D Spheroids in a High-Density Microfluidic Droplet ArrayCell Reports, 2020